Kestra Medical Technologies, Ltd. is a wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington.
| Revenue (TTM) | $83.72M |
| Gross Profit (TTM) | $40.81M |
| EBITDA | $-135.39M |
| Operating Margin | -141.60% |
| Return on Equity | -92.60% |
| Return on Assets | -36.80% |
| Revenue/Share (TTM) | $1.70 |
| Book Value | $4.94 |
| Price-to-Book | 5.47 |
| Price-to-Sales (TTM) | 19.42 |
| EV/Revenue | 15.89 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 62.70% |
| Shares Outstanding | $58.37M |
| Float | $32.77M |
| % Insiders | 5.32% |
| % Institutions | 102.87% |
Volatility is currently expanding
KIRKLAND, Wash., June 30, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report fourth quarter fiscal 2026 financial results after the market closes on Tuesday, July 14.
KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
KIRKLAND, Wash., April 22, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd.
